ANI PHARMACEUTICALS, INC (ANIP) Free cash flow 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$171.4MFY2025 · since FY2016: $22.9M → $171.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $171.4M | +258.7% |
| FY2024 | $47.8M | -56.6% |
| FY2023 | $110.1M | +374.7% |
| FY2022 | -$40.1M | -5339.1% |
| FY2021 | $765,000 | -91.6% |
| FY2020 | $9.1M | -76.6% |
| FY2019 | $39.0M | -36.4% |
| FY2018 | $61.3M | +111.1% |
| FY2017 | $29.1M | +26.8% |
| FY2016 | $22.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Net marginANIP Gross profitANIP Gross marginANIP Operating incomeANIP Operating marginANIP Operating cash flowANIP Capital expendituresANIP Return on equityANIP Stock buybacksANIP Dividends paidANIP Total assetsANIP Total liabilitiesANIP Shareholders’ equityANIP overview →